XBRANE BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2165 SEK | +4.09% |
|
-7.87% | -97.83% |
| Apr. 22 | Transcript : Xbrane Biopharma AB - Special Call | |
| Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Evolution of the average Target Price on Xbrane Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
d81e29a33ab65a681859368be7c1e3.PY34qQmVYSH7aQSx7-broOaAfiKcE3gGevblONxwmaU.CNSX9nvbIk3MMXPfipeR0bziS0_IZRsxOIeLeYsT9v1az7Hhc9sUDI8uaw~478c92a5670c182186aa4deff07fe8fe
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2165
SEK
Average target price
0.625
SEK
Spread / Average Target
+188.68%
High Price Target
0.65
SEK
Spread / Highest target
+200.23%
Low Price Target
0.6
SEK
Spread / Lowest Target
+177.14%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- XBRANE Stock
- Consensus Xbrane Biopharma AB
